FORT LAUDERDALE, Fla., Feb. 09, 2016 -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global provider of clinical data capture technology, announced that it will present at the eClinical Forum “Birds of a Feather” webinar on the topic of “eSource Strategies Between Electronic Health Records (EHR) and Electronic Data Capture (EDC)”. The presentation will focus on industry drivers for EDC to EHR integration, and review feedback from a recent eSource market survey conducted by OmniComm. OmniComm will also provide a proof-of-concept demonstration on how data can be pulled from an EHR system into the TrialMaster® EDC technology.
Integration between EHR and EDC is an evolving industry initiative to further streamline processes, reduce redundancy, expedite timelines, and contain costs in conducting clinical trials. However, there are significant implementation challenges involving data privacy, data standards, business workflows, and stakeholder collaboration. OmniComm’s presentation will explore various implementation alternatives to this quickly evolving trend.
“The eClinical Forum provides a unique opportunity for authorities representing sponsors, CROs, and technology vendors to collaborate on transformations, trends, and challenges as they relate to clinical trial systems, standards, and business processes,” stated Ken Light, EVP of transformation services, OmniComm Systems. “The Birds-of-a-Feather sessions are designed to provide collaboration and reach a broad representation of the global community.”
“OmniComm Systems has been a long-standing member of the eClinical Forum, regularly presenting at meetings and helping to deliver valued insight and thought leadership to our global member community,” stated Suzanne Bishop, Facilitator of eClinical Forum, North America. “Ken Light, Neil Vivian, and Dr. Yvonne Rollinger of OmniComm Systems are knowledgeable industry subject matter experts, with good perspectives on clinical technology trends, initiatives, and best practices. Registration for this upcoming seminar has been accruing at a record pace, with registrants from 12 countries and 3 continents - reflecting the timeliness and global appreciation of this particular topic.” Participation in the Birds-of-a-Feather webinar is open to anyone from an eClinical Forum member company, gratis.
Supporting Information
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit www.omnicomm.com.
About the eClinical Forum
The eClinical Forum was formed in 2000 to serve those members of the pharmaceutical and clinical research service industry who are or will be involved in handling electronic clinical research and related initiatives. It is a global, non-profit, non-commercial discussion/action group. Membership is open to all companies working within the clinical research arena. Information on the organization, operation, activities and membership of the eClinical Forum can be found at www.eclinicalforum.org.
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Dennis Constantinou OmniComm Systems, Inc. +1.954.473.1254 [email protected]


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



